The effects of the ethanolic extract of mahogany seeds (Swietenia macrophylla King) on the renal function of streptozotocin-induced diabetic rats ABSRACT Diabetes-associated oxidative stress causes glomerular hypertrophy, decrease of glomerular filtration rate and inhibits cell proliferation that lead to the decrease of renal function as indiated by the increase of serum creatinine level and the presence of protein in urine. Mahogany seed (Swietenia macrophylla King) has been proven to have antidiabetic activity. This study was conducted to evaluate the effect of the ethanolic extract of mahogany seeds on the renal function of streptozotocin-induced diabetic rats. Six normal rats as control (Group I) and 24 diabetic rats were used in this study. The diabetic rats were randomized allocated into four groups with six rats in each group. Group II was considered as diabetic rats control and received aquadest. Group III-V were considered as extract administered diabetic group and received ethanolic extract of S. macrophylla seed for 21 days at a dose of 50, 100 and 200 mg/kg BW, respectively. Serum malondialdehyde (MDA), serum creatinine, and urine protein levels were monitored, before and after the ethanolic extract of S. macrophylla seed administration. Serum MDA, serum creatinine and urine protein levels of all rats after STZ induction (Group II-V) were significantly higher than without STZ induction (p < 0.05). A significant decrease in the serum MDA and serum creatinine as well as urine protein levels were observed after the treatment with ethanolic extract of S. macrophylla seed compared to before treatment (p < 0.05). In conclusion, the ethanolic extract of S. macrophylla seed is able to correct renal dysfunction of streptozotocin-induced diabetic rats.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia due to a decrease in insulin secretion, insulin action, or both. 1 Complications of diabetes due to hyperglycemia includes macrovascular (coronary artery disease, peripheral arterial disease, and stroke) and microvascular (diabetic nephropathy, neuropathy, and retinopathy) dysfunctions. 2 Oxidative stress caused by hyperglycemia plays an important role in those macrovascular and microvascular complications of DM. 2, 3 Oxidative stress occurs as result of the increase of peroxidation product as a mediator of tissue damage and leads to the activation of pathogenesis complication pathways of DM. 3 Malondialdehyde (MDA) is a product of lipid peroxidation due to the increase of reactive oxygen species (ROS) level on the oxidative stress conditions. Plasma MDA is frequently used as biomarker for oxidative stress. In diabetics condition, plasma MDA level increases due to the decrease of antioxidant level and leads the early systemic complications of diabetes as expressed by the increased AGEs, protein, lipid serum, lymphocytes, and urine of diabetic patients. 4, 5 Moreover, oxidative stress causes glomerular hypertrophy, decrease of glomerular filtration rate and inhibits cell proliferation that lead to the decrease of renal function as indiated by the increase of serum creatinine level and the presence of protein in urine. [5] [6] [7] Previous studies showed the benefits and potential of some medicinal plants in dealing with oxidative stress in both the treatment of diabetes and its complication. 8 Mahogany (Swietenia macrophylla King) was proven to have antidiabetic activity. The aqueousmethanolic extract of the mahogany seed induces the pancreatic β cells regeneration and increases the insulin production due to its antioxidant activity through glucose autooxidant and protein glycation pathways. 9 In addition, the alcoholic mahogany seed extract stimulates the glucokinase enzyme, a major catalyst in the posporilation of glucose, in lowering blood glucose levels. 10 Streptozotocin (STZ) is widely used to induce experimental both insulin-dependent and non-insulin-dependent diabetes mellitus in animals, respectively. The mechanism of STZ action in β cells has been intensively investigated and is well understood.
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Streptozotocin entering the B cell via a glucose transporter (GLUT2) causes DNA damage due to alkylation of DNA. The DNA damage induces activation of poly ADP-ribosylation leads to depletion of cellular NAD + and ATP resulting in the formation of ROS. Moreover, STZ liberates toxic amounts of nitric oxide that inhibits aconitase activity and participates in DNA damage. As a result of the STZ action, β cells undergo the destruction by necrosis.
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The present study was designed to evaluate the effects of the ethanolic extract of mahogany seeds (S. macrophylla King) on the renal function of streptozotocin-induced diabetic rats. The renal function was expressed by serum creatinine and urinary protein levels. Furthermore, the plasma MDA level after the ethanolic administration was also evaluated.
MATERIALS AND METHODS

Ethanolic extract preparation
The S. macrophylla King seeds were collected in The Bogor Botanical Gardens, Indonesia and identified by a botanist in The 
Induction of diabetes by streptozotocin
Wistar strain male albino rats, 6-8 weeks of age, weighing from 180 to 200 g were selected for this study. All rats were acclimated for a period of 7 days in our laboratory condition prior to the study. Rats were housed at room temperature under 12 hours cycles of dark and light and were fed standard food and water ad libitum. Induction of diabetes in the rats were performed by a single intraperitoneal injection of STZ at dose of 60 mg/kg BW in 0.1 mL of freshly citrate buffer (0.01 M and pH = 4.5). The day of STZ injection was designated as day 0 (D-0). Development of diabetes was confirmed by measuring blood glucose level four days after STZ injection (D-4). Rats with the blood glucose level higher than 200 mg/dL were considered to be diabetic. The diabetic rats were then selected for the study. This study has been approved by Medical and Health Research Ethics Committee, Faculty of Medecine, Universitas Gadjah Mada, Yogyakarta.
Animal treatment
Six normal rats and 24 diabetic rats were used in this study. The normal rats were considered as non diabetic rats control and received aquadest (Group I). The diabetic rats were randomized allocated into four groups with six rats in each group. Group II was considered as diabetic rats control and received aquadest. Group III-V were considered as extract administered diabetic group and received ethanolic extract of S. macrophylla seed at a dose of 50, 100, and 200 mg/kg BW, respectively. The ethanolic extract was administered one time per day at 08.00 AM started from day 4 and continued for next 21 days. Blood glucose level was measured and monitored on day 0 (D-0), 4 (D-4), 18 (D-18) and 25 (D-25), respectively. In addition, serum creatinine, serum MDA and urine protein levels were also monitored, however only on day 4 (D-4) and 25 (D-25), respectively.
Biochemical analysis
A volume of 2 mL orbital sinus blood sample was collected from each study rat and assayed by standard methods for estimation of blood glucose, serum creatinine and MDA levels. The blood glucose level was measured by glucose oxidase peroxidase (GOP-PAP) method.14 The serum creatinine level was measured by Jaffe method 15 , MDA level was measured by TBARS metod 16 and urine protein level was measured by colorimetric test pyrogallon red metod. 17 All spectrophotometric measurements were carried out in a DR6000 UV-Visible spectrophotometer (Hach-US).
Statistical analysis
All the results were expressed as mean ± standard deviation (SD) for six animals in each group. Statistical comparisons were performed using one way analysis of variance (ANOVA) followed by Post Hoc Tests Least Significant Difference (LSD). p-values of less than 0.05 were considered to indicate statistical significance.
RESULTS
The effect of ethanolic extract of mahogany seeds on blood glucose level
Blood glucose level of all rats in all groups before STZ induction were in normal level (TABLE 1) . A significant increase in the level of blood glucose level was observed four days after STZ induction (D-4) when compared to before STZ induction (p < 0.05). All rats on Urine protein level of all rats four days after STZ induction (Group II-V) were significantly higher than without STZ induction (p < 0.05) (TABLE 3) 
DISCUSSION
In this study, STZ induction resulted in a significant increase in blood glucose level (Group II-V) compared to the control group (Group I). All rats on Group II-V had the blood glucose level higher than 200 mg/dL indicating the rats became diabetes. Diabetic Streptozotocin-induced diabetes has been described a useful experimental model to study the activity of antidiabetic agents. 18 Streptozoocin destroys β-cells of the pancreas and induces hyperglycemia. [11] [12] [13] 19 After administration of ethanolic extract of S. macrophylla seed to the diabetic rats on Group III-V for 21 days, a significant decrease in blood glucose level was observed which was close to the normal level (< 200 mg/dL). In addition, the antidiabetic effect of the ethanolic extract of S. macrophylla seed was in a dose-dependent manner (TABLE  1) . The antidiabetic effect of S. macropylla seed extract has been previously reported by some authors. 9, 10, 17 Its mechanism of action as antidiabetic has been also investigated. Kalaivanan et al. 10 reported that ethanolic extract of mahogany seed can increase insulin production and stimulate the regeneration of β-cells of the pancreas. Swietenia macropylla seed extract was also reported can activate the enzyme glucokinase in lowering blood glucose levels. 9 Moreover, Maiti et al. 20 and Dewanjee et al. 21 have successfully isolated swietenine, a tetranortriterpenoid, from the S. macrophylla seeds and have proven its hypoglycemic activity in type 2 diabetic rats.
Serum MDA level of rats four days after STZ induction significantly higher than without STZ induction indicating that oxidative stress developed in diabetic rats after STZ induction. After administration of ethanolic extract of S. macrophylla seed to the diabetic rats on Group III-V for 21 days, a significant decrease in serum MDA level was observed (TABLE 2) . It indicates that the ethanolic extract of S. macrophylla seed is able to correct the diabetes-induced oxidative stress. The ethanol extract of S. macrophylla seeds was proven to have antioxidant activity in the streptozotocin-induced diabetic rats. 17 Furthermore, the antioxidaive compounds from S. macropylla have been isolated such as swietemacrophyllanin, catechin, and epicatechin. 22 Serum creatinine and urine protein level of rats four days after STZ induction significantly higher than without STZ induction indicating the decrease of renal function. Diabetes-associated oxidative stress causes glomerular hypertrophy, decrease of glomerular filtration rate and inhibits cell proliferation that lead to the decrease of renal function. [5] [6] [7] After administration of ethanolic extract of S. macrophylla seed to the diabetic rats on Group III-V for 21 days, a significant decrease in serum creatinine and urine protein levels were observed (TABLE 3 and 4). It clearly demonstrates that the ethanolic extract of S. macrophylla seed is able to protect the decrease of renal function due to the diabetesinduced oxidative stress. As explained by Debasis et al. 9 , the renal protective effect of the extract of S. macrophylla seed may be explained by two ways. One way may be due to the insulinotrophic effect of this extract that results correction in blood glucose level that prevents the ROS generation by preventing glucose autooxidant and by glication. Another way may be the presence of antioxidative compounds in this extract that lowered the levels of end products of free radicals like MDA.
CONCLUSION
In conclusion, the ethanolic extract of mahogany seed (S. macropylla King) is able to correct renal dysfunction of streptozotocininduced diabetic rats as indicated by the decrease of serum creatinine and urine protein after administration of this extract. The renal protective effect of the ethanolic extract of mahogany seed may be due to its antidiabetic and antioxidant effects.
